Approvals begin to happen for 3 exciting treatment creams for psoriasis and eczema
There are three highly anticipated new topical creams for the treatment of psoriasis and eczema moving through the FDA clearance process as we write this blog. Two new unique creams for psoriasis For psoriasis, there has not been a novel non-steroidal topical medication approved in over twenty years. Thus, it is exciting that two unique creams have completed late-stage testing and are being reviewed by the FDA for potential authorization to prescribe within the next year. Roflumilast cream 0.3% targets inflammation by inhibiting PDE-4*. In two large pivotal** studies, roughly 40% of patients were clear or almost clear of psoriasis … Continue reading
